1. Home
  2. CRL vs FDS Comparison

CRL vs FDS Comparison

Compare CRL & FDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$260.72

Market Cap

10.8B

Sector

Health Care

ML Signal

HOLD

Logo FactSet Research Systems Inc.

FDS

FactSet Research Systems Inc.

HOLD

Current Price

$278.03

Market Cap

9.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRL
FDS
Founded
1947
1978
Country
United States
United States
Employees
N/A
6258
Industry
Biotechnology: Commercial Physical & Biological Resarch
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.8B
9.1B
IPO Year
1999
1996

Fundamental Metrics

Financial Performance
Metric
CRL
FDS
Price
$260.72
$278.03
Analyst Decision
Buy
Hold
Analyst Count
12
11
Target Price
$198.27
$284.80
AVG Volume (30 Days)
786.4K
764.7K
Earning Date
05-07-2026
03-31-2026
Dividend Yield
N/A
1.89%
EPS Growth
N/A
11.79
EPS
N/A
11.16
Revenue
$1,857,601,000.00
$1,435,351,000.00
Revenue This Year
N/A
$7.16
Revenue Next Year
$3.04
$5.55
P/E Ratio
N/A
$24.60
Revenue Growth
10.48
6.31
52 Week Low
$144.26
$185.00
52 Week High
$242.73
$396.06

Technical Indicators

Market Signals
Indicator
CRL
FDS
Relative Strength Index (RSI) 72.25 60.39
Support Level $153.47 $267.36
Resistance Level N/A $300.77
Average True Range (ATR) 8.53 11.31
MACD 0.51 1.05
Stochastic Oscillator 77.93 64.50

Price Performance

Historical Comparison
CRL
FDS

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About FDS FactSet Research Systems Inc.

FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for over 80% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.

Share on Social Networks: